IL-15 Regulates Both Quantitative and Qualitative Features of the Memory CD8 T Cell Pool
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Memory T cells are critical for immunity to various intracellular pathogens. Recent studies have indicated that CD8 secondary memory cells, induced by prime-boost approaches, show enhanced protective function compared with primary memory cells and exhibit phenotypic and functional characteristics that distinguish them from primary memory cells. However, little is known about the cytokine requirements for generation and maintenance of boosted memory CD8 T cells. We studied the role of IL-15 in determining the size and composition of the secondary (2°) memory CD8 T cell pool induced by Listeria monocytogenes infection in mice. Following boosting, IL-15–deficient animals failed to generate a subset of CD8 effector memory cells, including a population of IL-7Rαlow cells, which were prominent among secondary memory cells in normal mice. IL-15 deficiency also resulted in changes within the IL-7RαhighCD62Llow subset of 2° memory CD8 T cells, which expressed high levels of CD27 but minimal granzyme B. In addition to these qualitative changes, IL-15 deficiency resulted in reduced cell cycle and impaired Bcl-2 expression by 2° memory CD8 T cells, suggesting a role for IL-15 in supporting both basal proliferation and survival of the pool. Analogous qualitative differences in memory CD8 T cell populations were observed following a primary response to Sendai virus in IL-15−/− animals. Collectively, these findings demonstrate that IL-15 plays an important role in dictating the composition rather than simply the maintenance of the CD8 memory pool.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865 · cited 2×
“CD8 memory T cells produced following a single round of immunization, whereas vaccination protocols advocate repeated boosting to produce the most effective memory response (2, 7, 23, 24).”
BackgroundLineage relationship and protective immunity of memory CD8 T cell subsets
Wherry, E. J., Teichgräber, V., Becker, T. C., Masopust, D., Kaech, S. M., Antia, R., von Andrian, U. H., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni889 · Cited by 1,864
Joshi, N. S., Cui, W., Chandele, A., Lee, H. K., Urso, D. R., Hagman, J., Gapin, L., & Kaech, S. M. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.010 · Cited by 1,861
Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D., & Ahmed, R. (2003) · Nature Immunology · doi:10.1038/ni1009 · Cited by 1,830 · cited 3×
“It is worth reiterating that the CD127 subset is usually less prominent in the 1 ̊ memory CD8 T cell pool; therefore, despite access to physiological levels of IL-15, the majority of 1 ̊ memory cells re-express IL-7Ra, which seems critical for their differentiation from the effector stage (13, 14).”
Background
Cited by
Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development
van der Windt, G. J. W., Everts, B., Chang, C.-H., Curtis, J. D., Freitas, T. C., Amiel, E., Pearce, E. J., & Pearce, E. L. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.007 · Cited by 1,540
“…cytokines IL-2 and IL-15, which are critical for the development and maintenance of CD8+ Teff cells and memory T cells, respectively (Kennedy et al., 2000; Mitchell et al., 2010; Sandau et al., 2010; Schluns et al., 2002; Surh and Sprent, 2008; Tan et al., 2002; Zhang et al., 1998), influence SRC.”
BackgroundResultInfluentialInterleukin-2 Receptor Signaling: At the Interface between Tolerance and Immunity
Malek, T. R., & Castro, I. (2010) · Immunity · doi:10.1016/j.immuni.2010.08.004 · Cited by 851
Interleukin 12: still a promising candidate for tumor immunotherapy?
Lasek, W., Zagożdżon, R., & Jakobisiak, M. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1523-1 · Cited by 495
“Advantages of IL-15 in tumor immunotherapy result from its unique ability to activate important mechanisms of antitumor immunity, including development and activity of both NK cells [10–12] and CD8 T cells [13–16], and promoting a persistent immune response through its action on memory T cells [16–20].”
BackgroundGorina, R., Font‐Nieves, M., Márquez‐Kisinousky, L., Santalucia, T., & Planas, A. M. (2011) · Glia · doi:10.1002/glia.21094 · Cited by 471
Alizadeh, D., Wong, R. A., Yang, X., Wang, D., Pecoraro, J. R., Kuo, C.-F., Aguilar, B., Qi, Y., Ann, D. K., Starr, R., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0466 · Cited by 453
Wirth, T. C., Xue, H.-H., Rai, D., Sabel, J. T., Bair, T., Harty, J. T., & Badovinac, V. P. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.014 · Cited by 261
Effector-like CD8+ T Cells in the Memory Population Mediate Potent Protective Immunity
Olson, J. A., McDonald-Hyman, C., Jameson, S. C., & Hamilton, S. E. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.009 · Cited by 258
Self-citationDiacylglycerol kinases in T cell tolerance and effector function
Chen, S. S., Hu, Z., & Zhong, X.-P. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00130 · Cited by 44
“…for CD8 effector and memory responses (Becker et al., 2002; Kieper et al., 2002; Carrio et al., 2004; Bachmann et al., 2007; Cui and Kaech, 2010; Sandau et al., 2010; Feau et al., 2011; Boyman and Sprent, 2012; Van Der Windt et al., 2012; StarbeckMiller et al., 2014; Cui et al., 2015); SOCS1…”
Background
Metadata
- Authors
- Sandau, M. M., Kohlmeier, J. E., Woodland, D. L., & Jameson, S. C.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-12-14
- Volume
- 184
- Issue
- 1
- Pages
- 35-44
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1544769291
- Cited by
- 91
- References
- 4
- FWCI
- 3.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.